3 patient evaluations for ALS Phase 3 Study Dexpramipexole (KNS-760704) taken for the purpose of 'ALS (Amyotrophic Lateral Sclerosis)' with a perceived effectiveness rating of Can’t tell

AustinMJ
41200 thumb
AustinMJ
Sex: M
Data Quality: 1 star
Bulbar: none
Arms: mild
Chest: none
Legs: none
I am: g
I have:
ALS

See AustinMJ's full ALS Phase 3 Study Dexpramipexole (KNS-760704) history

Jan 16, 2013 (Started Aug 24, 2011)

  • Perceived effectiveness for ALS (Amyotrophic Lateral Sclerosis): Can’t tell
  • Side Effects: None
  • Adherence: Always
  • Burden: Not at all
Dosage: 300 mg Daily
Cost: < $25 monthly

Nov 26, 2012 (Started Aug 24, 2011)

  • Perceived effectiveness for ALS (Amyotrophic Lateral Sclerosis): Major
  • Side Effects: None
  • Adherence: Always
  • Burden: Not at all
Dosage: 300 mg Daily
Advice & Tips: Been rolled over to open-label for DEX. We hope to have a read-out soon (Dec/Jan) on results. I either have a really slow onset or this drug is really working... maybe both. While I've lost much strength in my right hand, all else is good for the last 2 years. My only negative was an early spike in Liver enzimines...
Cost: < $25 monthly

  • 0 helpful marks
Root10996
Portrait default thumb
Root10996
Sex: M
Data Quality: 1 star
Bulbar: none
Arms: severe
Chest: none
Legs: severe
I have:
ALS

See Root10996's full ALS Phase 3 Study Dexpramipexole (KNS-760704) history

Oct 10, 2012 (Started Sep 10, 2011)

  • Perceived effectiveness for Participate in clinical trial: Can’t tell
  • Perceived effectiveness for ALS (Amyotrophic Lateral Sclerosis): Can’t tell
  • Side Effects: None
  • Adherence: Always
  • Burden: Not at all
Dosage: 2 Daily

  • 0 helpful marks
jaws-als
35884 thumb
jaws-als
Sex: M
Data Quality: 2 stars
Bulbar: severe
Arms: severe
Chest: severe
Legs: severe
I am: vg
I have:
ALS

See jaws-als's full ALS Phase 3 Study Dexpramipexole (KNS-760704) history

Mar 26, 2012 (Started Jul 05, 2011)

  • Perceived effectiveness for ALS (Amyotrophic Lateral Sclerosis): Can’t tell
  • Side Effects: None
  • Adherence: Always
  • Burden: Not at all
Dosage: 300 mg Daily
Cost: < $25 monthly

Jul 20, 2011 (Started Jul 05, 2011)

  • Perceived effectiveness for ALS (Amyotrophic Lateral Sclerosis): Can’t tell
  • Side Effects: None
  • Adherence: Always
  • Burden: Not at all
Dosage: 300 mg Daily
Cost: < $25 monthly

  • 5 helpful marks
Last updated:
Showing 3 of 3 patient evaluations for ALS Phase 3 Study Dexpramipexole (KNS-760704)